Phase 1b study of tirabrutinib in combination with idelalisib or entospletinib in previously treated B-cell lymphoma
Authors
Morschhauser, F.Dyer, M. J. S.
Walter, H. S.
Danilov, A. V.
Ysebaert, L.
Hodson, D. J.
Fegan, C.
Rule, S. A.
Radford, John A
Cartron, G.
Bouabdallah, K.
Davies, A. J.
Spurgeon, S.
Rajakumaraswamy, N.
Li, B.
Humeniuk, R.
Huang, X.
Bhargava, P.
Jürgensmeier, J. M.
Salles, G.
Affiliation
Univ. Lille, CHU Lille, ULR 7365, GRITA - Groupe de Recherche sur les formes Injectables et les Technologies Associées, F-59000 Lille, France.Issue Date
2020
Metadata
Show full item recordCitation
Morschhauser F, Dyer MJS, Walter HS, Danilov AV, Ysebaert L, Hodson DJ, et al. Phase 1b study of tirabrutinib in combination with idelalisib or entospletinib in previously treated B-cell lymphoma. Leukemia. 2020.Journal
LeukemiaDOI
10.1038/s41375-020-01108-xPubMed ID
33328591Additional Links
https://dx.doi.org/10.1038/s41375-020-01108-xType
ArticleLanguage
enae974a485f413a2113503eed53cd6c53
10.1038/s41375-020-01108-x